Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Friberg

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2019
Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort studyAdriano Atterman, Leif Friberg, Kjell Asplund, et al.
The American Journal of Cardiology|June 25, 2021
Prognostic Implications of Supraventricular ArrhythmiasTove Hygrell, Martin Stridh, Leif Friberg, et al.
European Heart Journal|August 3, 2007
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)Leif Friberg, Niklas Hammar, Hans Pettersson, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 9, 2021
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and RisksAdriano Atterman, Leif Friberg, Kjell Asplund, et al.
Archives of Internal Medicine|June 22, 2002
Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?Leif Friberg, Sigbritt Werner, Gösta Eggertsen, et al.
Stroke|August 29, 2013
Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based studyStaffan Björck, Bo Palaszewski, Leif Friberg, et al.
Diabetes & Vascular Disease Research|October 21, 2017
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide reportStelios Karayiannides, Pia Lundman, Leif Friberg, et al.
European Heart Journal|April 12, 2014
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort studyLeif Friberg, Lina Benson, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 26, 2013
Atrial fibrillation patients do not benefit from acetylsalicylic acidSara Själander, Anders Själander, Peter J Svensson, et al.
BMC Cardiovascular Disorders|February 28, 2019
Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registersVenkatesh Kumar Gurusamy, Gunnar Brobert, Pareen Vora, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2019
Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort studyAdriano Atterman, Leif Friberg, Kjell Asplund, et al.
The American Journal of Cardiology|June 25, 2021
Prognostic Implications of Supraventricular ArrhythmiasTove Hygrell, Martin Stridh, Leif Friberg, et al.
European Heart Journal|August 3, 2007
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)Leif Friberg, Niklas Hammar, Hans Pettersson, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 9, 2021
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and RisksAdriano Atterman, Leif Friberg, Kjell Asplund, et al.
Archives of Internal Medicine|June 22, 2002
Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina?Leif Friberg, Sigbritt Werner, Gösta Eggertsen, et al.
Stroke|August 29, 2013
Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based studyStaffan Björck, Bo Palaszewski, Leif Friberg, et al.
Diabetes & Vascular Disease Research|October 21, 2017
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide reportStelios Karayiannides, Pia Lundman, Leif Friberg, et al.
European Heart Journal|April 12, 2014
Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort studyLeif Friberg, Lina Benson, Gregory Y H Lip
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 26, 2013
Atrial fibrillation patients do not benefit from acetylsalicylic acidSara Själander, Anders Själander, Peter J Svensson, et al.
BMC Cardiovascular Disorders|February 28, 2019
Sociodemographic factors and choice of oral anticoagulant in patients with non-valvular atrial fibrillation in Sweden: a population-based cross-sectional study using data from national registersVenkatesh Kumar Gurusamy, Gunnar Brobert, Pareen Vora, et al.
Pageof 8